Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potent Anti-SARS-CoV-2 Activity by the Natural Product Gallinamide A and Analogues via Inhibition of Cathepsin L
Anneliese S. Ashhurst, Arthur H. Tang, Pavla Fajtová, et al.
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 4, pp. 2956-2970
Open Access | Times Cited: 65

Showing 26-50 of 65 citing articles:

Discovery of novel SARS-CoV-2 3CL protease covalent inhibitors using deep learning-based screen
Liying Wang, Zhongtian Yu, Shiwei Wang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114803-114803
Open Access | Times Cited: 17
Intramolecular Interactions Enhance the Potency of Gallinamide A Analogues against Trypanosoma cruzi
Elany Barbosa da Silva, Vandna Sharma, Lilian Hernández Alvarez, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 5, pp. 4255-4269
Closed Access | Times Cited: 16
Structural understanding of SARS-CoV-2 virus entry to host cells
Kim Le, Shrute Kannappan, Truc Kim, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 9
Identification, optimization, and biological evaluation of 3-O-β-chacotriosyl ursolic acid derivatives as novel SARS-CoV-2 entry inhibitors by targeting the prefusion state of spike protein
Hui Li, Chen Cheng, Shi Shan-shan, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114426-114426
Open Access | Times Cited: 15
Omicsynin B4 potently blocks coronavirus infection by inhibiting host proteases cathepsin L and TMPRSS2
Yihua Li, Kun Wang, Hongmin Sun, et al.
Antiviral Research (2023) Vol. 214, pp. 105606-105606
Open Access | Times Cited: 8
Cyclopropane-Containing Specialized Metabolites from the Marine Cyanobacterium cf. Lyngbya sp.
Nurul Farhana Salleh, Jiale Wang, Binu Kundukad, et al.
Molecules (2023) Vol. 28, Iss. 9, pp. 3965-3965
Open Access | Times Cited: 8
Cathepsins and SARS‐CoV‐2 infection: From pathogenic factors to potential therapeutic targets
Shuxuan Zhao, Muzhou Jiang, Hong Qing, et al.
British Journal of Pharmacology (2023) Vol. 180, Iss. 19, pp. 2455-2481
Closed Access | Times Cited: 8
Broad-Spectrum Cyclopropane-Based Inhibitors of Coronavirus 3C-like Proteases: Biochemical, Structural, and Virological Studies
Chamandi S. Dampalla, Harry Nhat Nguyen, Athri D. Rathnayake, et al.
ACS Pharmacology & Translational Science (2022) Vol. 6, Iss. 1, pp. 181-194
Open Access | Times Cited: 12
Cathepsin inhibitors nitroxoline and its derivatives inhibit SARS-CoV-2 infection
Rafaela Milan Bonotto, Ana Mitrović, Izidor Sosič, et al.
Antiviral Research (2023) Vol. 216, pp. 105655-105655
Open Access | Times Cited: 7
Structure-Based Discovery of Thiosemicarbazones As SARS-CoV-2 Main Protease Inhibitors
Vinícius Gonçalves Maltarollo, Elany Barbosa da Silva, Thales Kronenberger, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 11, pp. 959-985
Closed Access | Times Cited: 7
New Hopes for Drugs against COVID-19 Come from the Sea
Orazio Taglialatela‐Scafati
Marine Drugs (2021) Vol. 19, Iss. 2, pp. 104-104
Open Access | Times Cited: 16
A computational simulation appraisal of banana lectin as a potential anti-SARS-CoV-2 candidate by targeting the receptor-binding domain
Sofia Safitri Hessel, Fenny Martha Dwivany, Ima Mulyama Zainuddin, et al.
Journal of Genetic Engineering and Biotechnology (2023) Vol. 21, Iss. 1, pp. 148-148
Open Access | Times Cited: 6
Discovery of 2-(furan-2-ylmethylene)hydrazine-1-carbothioamide derivatives as novel inhibitors of SARS-CoV-2 main protease
Xiaodong Dou, Qi Sun, Guofeng Xu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114508-114508
Open Access | Times Cited: 10
Cyanobacteria and their metabolites - can they be helpful in the fight against pathogenic microbes?
Łukasz Grabowski, Karolina Wiśniewska, Magdalena Żabińska, et al.
Deleted Journal (2024) Vol. 1, Iss. 1
Open Access | Times Cited: 1
Peptidomimetic Analogues Act as Effective Inhibitors against SARS-CoV-2 by Blocking the Function of Cathepsin L
Weilong Deng, Xiao Hu, Xiaoman Tian, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 19, pp. 17124-17143
Closed Access | Times Cited: 1
Marine Cyanobacteria: A Rich Source of Structurally Unique Anti-Infectives for Drug Development
Lik Tong Tan, Nurul Farhana Salleh
Molecules (2024) Vol. 29, Iss. 22, pp. 5307-5307
Open Access | Times Cited: 1
Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics
Jimena Pérez‐Vargas, Tirosh Shapira, Andrea Olmstead, et al.
Antiviral Research (2022) Vol. 209, pp. 105484-105484
Open Access | Times Cited: 8
Second generation synthesis of the anti-infective natural product gallinamide A
Arthur H. Tang, Richard J. Payne
Tetrahedron (2023) Vol. 139, pp. 133445-133445
Closed Access | Times Cited: 4
Metabolomic Analysis and Antiviral Screening of a Marine Algae Library Yield Jobosic Acid (2,5-Dimethyltetradecanoic Acid) as a Selective Inhibitor of SARS-CoV-2
Marie L. Matos-Hernández, Robert M. Samples, Grayce Dyer, et al.
Journal of Natural Products (2024) Vol. 87, Iss. 6, pp. 1513-1520
Closed Access | Times Cited: 1
The vital role of animal, marine, and microbial natural products against COVID-19
Aljawharah Alqathama, Rizwan Ahmad, Ruba B. Alsaedi, et al.
Pharmaceutical Biology (2022) Vol. 60, Iss. 1, pp. 509-524
Open Access | Times Cited: 7
Advances Toward COVID-19 Therapies Special Issue
Nouri Neamati
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 4, pp. 2713-2715
Closed Access | Times Cited: 6
Synthesis of indole-based ferulic acid derivatives and in vitro evaluation of antiviral activity against SARS-CoV-2
Marina Mol Sena Andrade Verzola, Daisymara Priscila de Almeida Marques, Elany Barbosa da Silva, et al.
Medicinal Chemistry Research (2023) Vol. 32, Iss. 10, pp. 2256-2267
Closed Access | Times Cited: 3
Discovery of pH-Selective Marine and Plant Natural Product Inhibitors of Cathepsin B Revealed by Screening at Acidic and Neutral pH Conditions
Von V. Phan, Charles Mosier, Michael C. Yoon, et al.
ACS Omega (2022) Vol. 7, Iss. 29, pp. 25346-25352
Open Access | Times Cited: 5
Clinical development of antivirals against SARS-CoV-2 and its variants
Qiaoshuai Lan, Yan Yan, Guangxu Zhang, et al.
Current Research in Microbial Sciences (2023) Vol. 6, pp. 100208-100208
Open Access | Times Cited: 2
Cytoskeletal β-tubulin and cysteine cathepsin L deregulation by SARS-CoV-2 spike protein interaction with the neuronal model cell line SH-SY5Y
Bernardo R. Oliveira, Inga Nehlmeier, Amy Kempf, et al.
Biochimie (2024) Vol. 226, pp. 49-61
Open Access

Scroll to top